MPC Therapeutics

MitoImmune Therapeutics

This biotechnology firm develops mitochondrial-targeted therapies for patients with inflammatory and rare diseases, including cancer treatment side effects like oral mucositis.

Mnemo Therapeutics

This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.

Eigen Therapeutics

The company develops AI-enabled priming therapies to enhance the effectiveness of targeted cancer treatments for healthcare providers and pharmaceutical patients.

Mosaic Therapeutics

The company develops targeted oncology drug combinations and biomarker-defined therapies for cancer patients and healthcare providers.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Mighty Therapeutics

This company develops mitochondrial-targeted therapies for patients with rare genetic conditions like Barth syndrome and common age-related diseases.

Tcubeit

This company develops T cell manufacturing platforms and immunotherapy pipelines for pharmaceutical firms and research institutions treating cancer and rare diseases.

C4 Therapeutics

This biopharmaceutical company develops small-molecule medicines that degrade disease-causing proteins to treat cancer and other difficult diseases for patients and healthcare providers.